App Teaches Doctors to Diagnose Skin Cancer

Melanoma (Skin) Clinical Trial

Official title:

Improving Diagnostic Accuracy in Skin Cancer Diagnostics Using Educational Mobile App: a Randomized Controlled Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05661370
• Other study ID #: GP-Learn
• Status: Completed
• Phase: N/A
• Start date: November 15, 2021
• Est. completion date: August 15, 2022

Study information

• Verified date: July 2023
• Source: Herlev Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aimed to examine if self-paced learning with a novel digital patient-case-based educational platform can increase primary care physicians' diagnostic accuracy of malignant and benign skin lesions on both the level of benign/malignant and the diagnosis level. Secondarily the study aimed to investigate the time spent in reaching this change in proficiency.

Description:

Participants were given a questionnaire and an initial Skin Cancer Multiple Choice-Questionnaire (MCQ) to test their diagnostic skills regardining skin and mole cancer and the most common differential diagnoses.

Participants in the Intervention group was then given access to an educational mobile application (App) for 8 days and asked to diagnose 500 patient cases. The participants did so at their own leisure and time.

After 8 days they were asked to abstain from using the App for another 8 days (wash out period) and were then given a Final Skin Cancer Multiple Choice-Questionnaire (MCQ).

Participants of the control group received no intervention nor education during the 16 days of waiting before they took the final Skin Cancer Multiple Choice-Questionnaire.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 3
• Est. completion date: August 15, 2022
• Est. primary completion date: January 15, 2022
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 120 Years

Eligibility

Inclusion Criteria:

• Primary Care Physician who works in General Practice

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Carcinoma
• Melanoma
• Melanoma (Skin)
• Skin Neoplasms

Intervention

Other:
• Dermloop Learn
Educational Mobile Application with a library of digital patient-cases and written learning modules the user can access on 36 common skin lesions, both benign and malignant.

Locations

Country	Name	City	State
Denmark	AISC Research Fascility	Copenhagen	Danmark

Sponsors (1)

Lead Sponsor	Collaborator
Herlev Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Multiple-Choice Questionnaire (MCQ) Score	Participants are given a test before and after the intervention using a skin cancer MCQ test with 12 digital-patient cases. A higher score means better diagnostic proficiency. The primary outcome is the change of this score.	Before and immediately after intervention (On average 19 days after enrollment)
Secondary	Diagnostic proficiencies	Sensitivity, Specificity and Positive Predictive Value of the participants in the intervention group, calculated on their cases seen in the educational mobile application.	During the 8 days of access to the educational mobile application.
Secondary	Time spend	The Dermloop Learn app tracks how much time each user spends quizzing and reading.	During the 8 days of access to the educational mobile application.